Skip to main content
See every side of every news story
Published loading...Updated

Pixelworks to Announce Third Quarter 2025 Financial Results on November 11

Senseonics reported 90% revenue growth driven by U.S. patient growth and plans to resume commercial control of Eversense CGM system with a Nasdaq listing planned for Q3 2025.

  • On Nov. 05, 2025, Senseonics Holdings, Inc. reported third-quarter results and hosted a conference call at 4:30 pm Eastern Time with a replay on its investor website.
  • The company pointed to direct-to-consumer marketing and a 160% increase in U.S. new patient starts, along with an MOU with Ascensia Diabetes Care to transition Eversense commercial responsibility back to Senseonics.
  • The results show concrete numbers: $8.1 million in Q3 revenue, $6.4 million U.S. sales, $1.7 million outside U.S., $19.5 million net loss, and $3.5 million gross profit.
  • The company also took corporate steps by executing a 1-for-20 reverse stock split to approximately 41 million shares and planning a Nasdaq Global Market listing for November 17th.
  • Looking ahead, Senseonics expects CE Mark approval for Eversense 365 by year-end and EU launch in H1 2026, assumes doubling global patient base in 2025, and cautions on risks affecting projections.
Insights by Ground AI

152 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 51% of the sources are Center
51% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Watauga Democrat broke the news in Calhoun, United States on Monday, November 3, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal